Overview

* Premier fiscal Q1 2026 revenue missed analyst expectations, declining 3% yr/yr

* Adjusted EPS for fiscal Q1 beats consensus, despite a 12% yr/yr decrease

* Company suspends dividend distribution due to pending acquisition by Patient Square Capital

Outlook

* Premier withdraws fiscal-year 2026 guidance due to pending acquisition

* Company suspends common stock dividends amid acquisition

* Contigo Health wind-down expected by December 31, 2025

Result Drivers

* PERFORMANCE SERVICES DECLINE - Performance Services segment revenue decreased 9% due to lower license revenue, partially offset by consulting growth and IllumiCare acquisition contributions

* SUPPLY CHAIN SERVICES GROWTH - Software licenses and other services revenue increased 5% driven by new engagements and digital solutions expansion

* NET INCOME IMPACT - Decrease in net income from continuing operations due to absence of prior-year non-operating gain from lawsuit settlement

Key Details

Metric Beat/Mis Actual Consensu

s s

Estimate

Q1 Miss $240 mln $240.87

Revenue mln (6

Analysts

)

Q1 Beat $0.30 $0.27 (6

Adjusted Analysts

EPS )

Q1 Beat $25.05 $22.23

Adjusted mln mln (6

Net Analysts

Income )

Analyst Coverage

* The current average analyst rating on the shares is "hold" and the breakdown of recommendations is no "strong buy" or "buy", 7 "hold" and no "sell" or "strong sell"

* The average consensus recommendation for the advanced medical equipment & technology peer group is "buy."

* Wall Street's median 12-month price target for Premier Inc ( PINC ) is $28.25, about 0.2% above its November 3 closing price of $28.19

* The stock recently traded at 20 times the next 12-month earnings vs. a P/E of 15 three months ago

Press Release:

For questions concerning the data in this report, contact [email protected]. For any other questions or feedback, contact .

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)